Impact of COVID-19 on social determinants of health for adults with cystic fibrosis.


Journal

Therapeutic advances in respiratory disease
ISSN: 1753-4666
Titre abrégé: Ther Adv Respir Dis
Pays: England
ID NLM: 101316317

Informations de publication

Date de publication:
Historique:
entrez: 23 8 2021
pubmed: 24 8 2021
medline: 31 8 2021
Statut: ppublish

Résumé

Outcomes in cystic fibrosis are influenced by multiple factors, including social determinants of health. Low socioeconomic status has been shown to be associated with lung function decline, increased exacerbation rates, increased health care utilization, and decreased survival in cystic fibrosis. The COVID-19 pandemic disrupted the US economy, placing people with cystic fibrosis at risk for negative impacts due to changes in social determinants of health. To characterize the impact of COVID-19-related changes in social determinants of health in the adult cystic fibrosis population, a social determinants of health questionnaire was designed and distributed to patients as part of a quality improvement project. Of 132 patients contacted, 76 (57.6%) responses were received. Of these responses, 22 (28.9%) answered yes to at least one question that indicated an undesired change in social determinants of health. Patients with stable employment prior to COVID-19 were more likely to endorse undesired change in all domains of the questionnaire, and the undesired changes were most likely to be related to employment, insurance security, and access to medications. Patients receiving disability were more likely to report hardship related to utilities and food security compared with patients previously employed or unemployed. Of patients endorsing risk of socioeconomic hardship, 21 (95.5%) were contacted by a social worker and provided resources. Utilizing a social determinants of health questionnaire to screen for social instability in the context of COVID-19 is feasible and beneficial for patients with cystic fibrosis. Identifying social issues early during the pandemic and implementing processes to provide resources may help patients with cystic fibrosis mitigate social hardship and maintain access to health care and medications.

Identifiants

pubmed: 34420457
doi: 10.1177/17534666211037459
pmc: PMC8381410
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17534666211037459

Références

BMC Public Health. 2021 Apr 8;21(1):685
pubmed: 33832478
Ann Intern Med. 2017 Apr 18;166(8):537-546
pubmed: 28288488
J Pediatr. 1998 Feb;132(2):260-4
pubmed: 9506638
Pediatrics. 2003 Apr;111(4 Pt 1):e333-9
pubmed: 12671148
Am J Respir Crit Care Med. 2001 May;163(6):1331-7
pubmed: 11371397
Chest. 2010 Mar;137(3):642-50
pubmed: 19820076
Expert Rev Respir Med. 2016 Sep;10(9):967-77
pubmed: 27268142
Front Public Health. 2020 Jul 21;8:406
pubmed: 32793544
Lancet Respir Med. 2020 Jul;8(7):659-661
pubmed: 32437646
Prev Chronic Dis. 2020 Oct 01;17:E119
pubmed: 33006541
J Epidemiol Community Health. 2021 Jan 5;:
pubmed: 33402397
Am J Health Promot. 2020 Jul;34(6):687-689
pubmed: 32551932
Semin Respir Crit Care Med. 2003 Dec;24(6):639-52
pubmed: 16088580
PLoS One. 2021 Mar 31;16(3):e0248336
pubmed: 33788848
J Pediatr. 2009 Nov;155(5):634-9.e1-4
pubmed: 19608199

Auteurs

Dana Albon (D)

Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia Health System, Charlottesville, VA, USA.

Heather Bruschwein (H)

Department of Psychiatry and Neurobehavioral Sciences, University of Virginia Health System, PO Box 800223, Charlottesville, VA 22908, USA.

Morgan Soper (M)

Department of Social Work, University of Virginia Health System, Charlottesville, VA, USA.

Rhonda List (R)

Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia Health System, Charlottesville, VA, USA.

Deirdre Jennings (D)

Department of Social Work, University of Virginia Health System, Charlottesville, VA, USA.

Lucy Gettle (L)

Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia Health System, Charlottesville, VA, USA.

Martina Compton (M)

Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia Health System, Charlottesville, VA, USA.

Molly Bailey (M)

Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia Health System, Charlottesville, VA, USA.

Elissa Starheim (E)

Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia Health System, Charlottesville, VA, USA.

Rachel Murray (R)

Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia Health System, Charlottesville, VA, USA.

John Kalmanek (J)

School of Medicine, University of Virginia, Charlottesville, VA, USA.

Lindsay Somerville (L)

Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia Health System, Charlottesville, VA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH